Source: Health Canada shortage reports · Updated Nov 5, 2026
Some Caspofungin products are in shortage in Canada (1 of 6 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Oct 30, 2027.
An antifungal medication used to treat serious fungal infections.
Products affected
1 / 6
Est. full return
Oct 30, 2027
Reports on file
18
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
CASPOFUNGIN FOR INJECTION
50MG · POWDER FOR SOLUTION · FRESENIUS KABI CANADA LTD
DIN 02486989 · since ?, est. end Oct 30, 2027 · Disruption of the manufacture of the drug.
To be discontinued
CASPOFUNGIN FOR INJECTION
70MG · POWDER FOR SOLUTION · FRESENIUS KABI CANADA LTD
DIN 02486997
To be discontinued
CANCIDAS
70MG · POWDER FOR SOLUTION · MERCK CANADA INC
DIN 02244266
Discontinued
CANCIDAS
50MG · POWDER FOR SOLUTION · MERCK CANADA INC
DIN 02244265
Resolved
CASPOFUNGIN FOR INJECTION
50MG · POWDER FOR SOLUTION · FRESENIUS KABI CANADA LTD
DIN 02486989 · ended Sep 26, 2024 · Disruption of the manufacture of the drug.
Resolved
CASPOFUNGIN FOR INJECTION
50MG · POWDER FOR SOLUTION · JUNO PHARMACEUTICALS CORP.
DIN 02460947 · ended Aug 6, 2024 · Disruption of QC release testing schedule
Resolved
CASPOFUNGIN FOR INJECTION
70MG · POWDER FOR SOLUTION · JUNO PHARMACEUTICALS CORP.
DIN 02460955 · ended Aug 6, 2024 · Delays in QC testing schedules
Resolved
CASPOFUNGIN FOR INJECTION
50MG · POWDER FOR SOLUTION · FRESENIUS KABI CANADA LTD
DIN 02486989 · ended Feb 29, 2024 · Disruption of the manufacture of the drug.
Resolved
CASPOFUNGIN FOR INJECTION
50MG · POWDER FOR SOLUTION · JUNO PHARMACEUTICALS CORP.
DIN 02460947 · ended Jan 17, 2024 · Demand increase for the drug.
Resolved
CASPOFUNGIN FOR INJECTION
70MG · POWDER FOR SOLUTION · JUNO PHARMACEUTICALS CORP.
DIN 02460955 · ended Jan 17, 2024 · Demand increase for the drug.
Resolved
CANCIDAS
50MG · POWDER FOR SOLUTION · MERCK CANADA INC
DIN 02244265 · ended Dec 14, 2023 · Delay in shipping of the drug.
Resolved
CANCIDAS
70MG · POWDER FOR SOLUTION · MERCK CANADA INC
DIN 02244266 · ended Nov 29, 2023 · Demand increase for the drug.
Showing 12 of 18 reports. All reports are on file with Health Canada.
What's happening
Caspofungin is currently affected by an active shortage report filed with Health Canada by FRESENIUS KABI CANADA LTD.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Caspofungin is classified under “ANTIMYCOTICS FOR SYSTEMIC USE” (ATC J02AX).
Recent changes
Nov 5, 2026
Status changed
Oct 1, 2026
New report filed
Jul 31, 2026
New report filed
Common questions
What is Caspofungin used for?
An antifungal medication used to treat serious fungal infections.
When will Caspofungin be back in stock in Canada?
The latest manufacturer estimate is Oct 30, 2027. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Caspofungin in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.